Literature DB >> 24451532

Immunotherapy: Natural killers take on cancer.

Jacques Zimmer1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24451532     DOI： 10.1038/505483e

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Cancer immunotherapy.

Authors:  Lauren Gravitz
Journal:  Nature       Date:  2013-12-19       Impact factor: 49.962

Review 2.  NK cell-based immunotherapy for malignant diseases.

Authors:  Min Cheng; Yongyan Chen; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

3.  Combination immune therapies to enhance anti-tumor responses by NK cells.

Authors:  Ashley Mentlik James; Adam D Cohen; Kerry S Campbell
Journal:  Front Immunol       Date:  2013-12-23       Impact factor: 7.561
  3 in total
  3 in total

1.  Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.

Authors:  Dan Chen; Huanhuan Sha; Tianmu Hu; Shuchen Dong; Junying Zhang; Siwen Liu; Haixia Cao; Rong Ma; Yang Wu; Changwen Jing; Zhuo Wang; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

Review 2.  Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.

Authors:  Antonino Bruno; Lorenzo Mortara; Denisa Baci; Douglas M Noonan; Adriana Albini
Journal:  Front Immunol       Date:  2019-04-18       Impact factor: 7.561

3.  Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer.

Authors:  Mei-Ren Pan; Cheng-Che Wu; Jung-Yu Kan; Qiao-Lin Li; Shu-Jyuan Chang; Chun-Chieh Wu; Chung-Liang Li; Fu Ou-Yang; Ming-Feng Hou; Hon-Kan Yip; Chi-Wen Luo
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.